These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 10703328)
21. Trimetrexate as a biochemical modulator of 5-fluorouracil and leucovorin in colorectal cancer. Punt CJ Semin Oncol; 2000 Oct; 27(5 Suppl 10):88-90. PubMed ID: 11049038 [No Abstract] [Full Text] [Related]
24. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. Thirion P; Michiels S; Pignon JP; Buyse M; Braud AC; Carlson RW; O'Connell M; Sargent P; Piedbois P; J Clin Oncol; 2004 Sep; 22(18):3766-75. PubMed ID: 15365073 [TBL] [Abstract][Full Text] [Related]
25. The relationship between tumor metabolism and 5-fluorouracil resistance. Hu J; Li A; Guo Y; Ma T; Feng S Biochem Pharmacol; 2023 Dec; 218():115902. PubMed ID: 37922975 [No Abstract] [Full Text] [Related]
26. Correlations between thymidylate synthase expression and chemosensitivity to 5-fluorouracil, cell proliferation and clinical outcome in head and neck squamous cell carcinoma. Yasumatsu R; Nakashima T; Uryu H; Ayada T; Wakasaki T; Kogo R; Masuda M; Fukushima M; Komune S Chemotherapy; 2009; 55(1):36-41. PubMed ID: 19023200 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic drug monitoring of cytotoxic drugs. Lennard L Br J Clin Pharmacol; 2001; 52 Suppl 1(Suppl 1):75S-87S. PubMed ID: 11564055 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic drug monitoring of antimetabolic cytotoxic drugs. Lennard L Br J Clin Pharmacol; 1999 Feb; 47(2):131-43. PubMed ID: 10190647 [TBL] [Abstract][Full Text] [Related]
30. [Effects of expression of thymidine phosphorylase induced by gamma-interferon on regulation of antineoplastic activity of fluorouracil on colonic cancer]. Yu XQ; Deng CS; Zhu YQ; Cheng FZ Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):568-70. PubMed ID: 15949342 [No Abstract] [Full Text] [Related]
31. Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule. Guo XD; Harold N; Saif MW; Schuler B; Szabo E; Hamilton JM; Monahan BP; Quinn MG; Cliatt J; Nguyen D; Grollman F; Thomas RR; McQuigan EA; Wilson R; Takimoto CH; Grem JL Cancer Chemother Pharmacol; 2003 Jul; 52(1):79-85. PubMed ID: 12707718 [TBL] [Abstract][Full Text] [Related]
32. Effectiveness of adjuvant fluorouracil in elderly colon cancer patients: the internal and external validity of nonrandomized research design. Apolone G; Cavuto S; Torri V; la Vecchia C J Clin Oncol; 2003 May; 21(9):1892; author reply 1893. PubMed ID: 12721271 [No Abstract] [Full Text] [Related]
36. Influence of pyrazofurin on the toxicity and antitumor activity of fluorinated pyrimidines in vivo. Johnson RK; Howard WS; Faucette LF; Wodinsky I; Clement JJ Adv Enzyme Regul; 1980; 19():309-33. PubMed ID: 7337031 [No Abstract] [Full Text] [Related]
37. Potentiation by 2-deoxy-D-glucose tetraacetate of the antitumoral action of 5-fluorouracil in mice inoculated with L1210 ascites-producing cells. Olivares E; Kadiata MM; Malaisse WJ Oncol Rep; 1999; 6(6):1309-11. PubMed ID: 10523703 [TBL] [Abstract][Full Text] [Related]